Market Exclusive

Analyst Activity – SunTrust Banks Initiates Coverage On Dicerna Pharmaceuticals (NASDAQ:DRNA) With a Buy

Analyst Ratings For Dicerna Pharmaceuticals (NASDAQ:DRNA)

Today, SunTrust Banks initiated coverage on Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy with a price target of $13.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Dicerna Pharmaceuticals (NASDAQ:DRNA)
Dicerna Pharmaceuticals (NASDAQ:DRNA) has insider ownership of 29.41% and institutional ownership of 22.76%.

Recent Trading Activity for Dicerna Pharmaceuticals (NASDAQ:DRNA)
Shares of Dicerna Pharmaceuticals closed the previous trading session at with shares trading hands.

Exit mobile version